Patents - stay tuned to the technology

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


48th week of 2008 patent applcation highlights part 48
Patent application numberTitlePublished
20080293779Methods of treating humans undergoing injection of a contrast agent - A human undergoing an injection of a contrast agent is treated by the administration of an iron chelator. Administration of the iron chelator can essentially prevent the onset of acute renal failure in a human. Administration of the iron chelator can reduce the severity of the acute renal failure and/or reduce the severity of kidney disease consequent to the acute renal failure.2008-11-27
20080293780BICYCLIC ARYL-SULFONIC ACID [1,3,4]-THIADIAZOL-2-YL-AMIDES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USE - The present invention comprises bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, their functional derivatives thereof as well as their physiologically acceptable salts and pharmaceutical compositions thereof that exhibit peroxisome proliferator activated receptor (PPAR) PPARdelta and PPARgamma agonist activity. The structure of the compounds of the invention are defined by Formula I below,2008-11-27
20080293781Salicylic Acid Derivatives - The present invention refers to O-acyl salicylic acid derivatives (I) bearing a NO donor moiety, a process for their preparation and pharmaceutical compositions containing them. (I) wherein: D is ONO2008-11-27
200802937821,1,3-Trioxo-1,2,5-Thiadiazolidines and Their Use as Ptp-Ases Inhibitors - Compounds of the formula2008-11-27
20080293783OXADIAZOLYL-PHENOXYALKYLISOXAZOLES, COMPOSITIONS THEREOF AND METHODS FOR THEIR USE AS ANTI-PICORNAVIRAL AGENTS - Oxadiazolyl-phenoxyalkylisoxazoles and pharmaceutically acceptable salts thereof, compositions comprising oxadiazolyl-phenoxyalkylisoxazole compounds or pharmaceutically acceptable salts thereof and methods for using oxadiazolyl-phenoxyalkylisoxzazole compounds or pharmaceutically acceptable salts thereof as anti-picornaviral agents are described herein. The methods include using pleconaril as a prodrug for conversion to anti-picornaviral compounds in vivo.2008-11-27
20080293784EPOTHILONES C, D, E AND F, PREPARATION AND COMPOSITIONS - The present invention relates to epothilones C, D, E and F, their preparation and their use for the production of therapeutic compositions and compositions for plant protection.2008-11-27
20080293785SUBSTITUTED BENZOTHIAZOLE KINASE INHIBITORS - The present invention is directed to substituted benzothiazole compounds of formula (I):2008-11-27
20080293786NOVEL 2-IMINO-1,3-THIAZOLINE-BASED COMPOUNDS AND T-TYPE CALCIUM CHANNEL INHIBITORS CONTAINING THE SAME - Novel 2-imino-1,3-thiazoline based compounds represented by Chemical Formula I, and T-type calcium channel inhibitors containing the compound are provided. The T-type calcium channel inhibitors according to the present invention are useful as a treating agent of diseases associated with over-expression of the T-type calcium channel.2008-11-27
20080293787PHARMACEUTICAL COMPOSITIONS FOR POORLY SOLUBLE DRUGS - The invention relates to solid dispersions of poorly soluble compounds formed by co-precipitation and hot melt extrusion, resulting in improved stability and bioavailability. The invention also relates to hot melt extrusion processes used to prepare such solid dispersions.2008-11-27
20080293788Methods and Compositions for the Treatment of Pulmonary Diseases - This invention related to methods of treating, preventing and managing various pulmonary diseases or disorders using formoterol in combination with calcium activated potassium channel openers. Pharmaceutical compositions comprising formoterol and calcium activated potassium channel openers are also disclosed.2008-11-27
20080293789VALSARTAN FORMULATIONS - The present invention relates to a new pharmaceutical formulation in the form of a tablet consisting of valsartan as an active agent, pregelatinized starch, microcrystalline cellulose.2008-11-27
20080293790SUBSTITUTED ARYL OXIMES - The present invention relates to substituted aryl oximes and methods of using them.2008-11-27
20080293791VALSARTAN SALTS - The invention relates to new salts of valsartan or crystalline, also partly crystalline and amorphous salts of valsartan, the respective production and usage, and pharmaceutical preparations containing such a salt.2008-11-27
20080293792Tocopherol derivatives and uses thereof - Tocopherol derivatives having the general formula:2008-11-27
20080293793Fungicidal Mixtures for Wood Preservation - Using synergistically effective mixtures comprising triadimefon and/or triadimenol and at least one further known fungicidally active compound, it is possible to protect industrial materials, in particular wood, against attack, damage and/or destruction by biological pests, in particular by wood-destroying fungi.2008-11-27
20080293794DIARYLTRIAZOLMETHYLAMINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF - The invention concerns compounds of formula (I):2008-11-27
20080293795COMBINATION THERAPY WITH PARP INHIBITORS - The present invention describes benzimidazole derivatives of Formula (I) which constitute potent PARP inhibitors in combination with temozolomide (TMZ).2008-11-27
20080293796Parenteral and oral formulations of benzimidazoles - Provided herein are drug delivery systems comprising nanosuspension formulations suitable for parenteral delivery to a subject. The nanosuspension formulations may comprise a benzimidazole derivative, e.g., mebendazole, and surface stabilizers, such as block copolymer(s), e.g., Pluronic F108, and surfactant(s), e.g., Tween 80, and, optionally, water. Provided are methods for defining nanosuspensions of a benzimidazole derivative as having maximum therapeutic efficacy for a treatment regimen by adjusting and/or selecting particles size(s) based on pharmacokinetic parameters of the derivative in the tissue. Also provided are methods for improving the bioavailability of a benzimidazole derivative during treatment of a pathophysiological condition and for treating a cancer by using formulation(s) combining particle diameters whereby the retention of the benzimidazole derivative within the particles increases as the diameter increases such that, upon administration, release of the benzimidazole derivative from the particles into tissue is continuous over a range of time as determined by the particle diameters.2008-11-27
20080293797Cycloalkane-Substituted Pyrazoline Derivatives, Their Preparation and Use as Medicaments - The present invention relates to Cycloalkane-substituted pyrazoline compounds of formula (I), methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans and animals.2008-11-27
20080293798Fungicidal Mixtures Comprising Substituted 1-Methylpyrazol-4-Ylcarboxanilides - Fungicidal mixtures, comprising as active components 2008-11-27
20080293799Liver Function Ameliorant - The present invention relates to a liver function ameliorant containing orniplabin as an active ingredient thereof.2008-11-27
20080293800Cytotoxic Compounds and Conjugates - The present disclosure provides cytoxic compounds useful as drugs or prodrugs and to drug-cleavable substrate conjugates where the drug and cleavable substrate are optionally linked through a self-immolative linker.2008-11-27
20080293801Solid Amorphous Dispersions of An Mtp Inhibitor For Treatment of Obesity - A composition comprises a solid amorphous dispersion comprising (S)—N-{2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl}-methyl-5-[4′-(trifluoromethyl)[1,1′-biphenyl]-2-carboxamido]-1H-indole-2-carboxamide and a polymer.2008-11-27
20080293802Chemical Compounds - The invention is directed to novel indole carboxamide derivatives. Specifically, the invention is directed to compounds according to formula (I).2008-11-27
20080293803MELATONIN DAILY DOSAGE UNITS - The present invention relates to a disposable container for a medicament or cosmetic agent for topical application, containing a single dose of melatonin or of a melatonin derivative which corresponds to a locally effective dose but which does not cause any systemic effect.2008-11-27
20080293804Pharmaceutical Nasal Spray Formulation of Acetaminophen (paracetamol) - The invention in question is a novel pharmaceutical formulation that comprises a one percent weight by volume Paracetamol in a phosphate buffer adjusted to pH 7.4 by addition of few drops of 1.0 N NaOH. The concentrations of the ingredients were chosen such that the resulting solution is isotonic with body fluids. Said concentrations were theoretically calculated based on their sodium chloride equivalents. The formulation is meant to be used as a nasal spray.2008-11-27
20080293805DRUG DELIVERY SYSTEM AND THE PREPARING METHOD THEREOF - A drug delivery system comprises a liposome and at least one charged nanoparticle. The liposome has at least an internal lipid layer and an external lipid layer, wherein the internal lipid layer forms an interior space for accommodating a drug. The charged nanoparticle is reversibly associated with an exterior surface of the external lipid layer of the liposome.2008-11-27
20080293806Odor Reduction Compositions - An odor-reducing composition for counteracting malodour in which the composition includes an odor reducing material of the type phenyl ethyl methyl ether, Cyprisate, Camonal and paracresyl methyl ether and a method for counteracting malodour employing such a composition.2008-11-27
20080293807Skin Cosmetic and Wrinkle-Reducing Agent - It is intended to provide a skin cosmetic and a wrinkle-reducing agent which are excellent in improving wrinkles caused by photoaging. Namely, a skin cosmetic and a wrinkle-reducing agent containing isosorbide which is represented by the following structural formula (1).2008-11-27
20080293808Non-Steroidal Androgen Receptor Modulators, Preparation Process, Pharmaceutical Composition and Use Thereof - Non-steroidal androgen receptor modulating compounds of the general formula (I), their pharmaceutically acceptable salts, preparation process and pharmaceutically compositions containing the said compounds are disclosed. Such compounds of the general formula (I) or their pharmaceutically acceptable salts can be used for preparing non-steroidal medicines to treat and/or prevent conditions or diseases such as prostatic hyperplasia, prostate cancer, hirsutism, severe hormone-dependent alopecia or acne, etc. as a result of androgen receptor antagonistic activities.2008-11-27
20080293809Pest control formulation - The present invention relates to a pest control composition that includes a pest control active ingredient and a polyoxypropylene-polyoxyethylene ether of a long chain fatty alcohol as an agent to reduce or eliminate paraesthesia of the active ingredient to a warm blooded mammal. The system releases the active ingredient efficiently and uniformly. The pest control formulation is less irritating to the animal's skin as compared to prior art systems. The formulation is useful for making animal collars, ear tags, pest strips, liquid spot-on treatments, and the like.2008-11-27
20080293810MULTI-DOSE CONCENTRATE ESMOLOL WITH BENZYL ALCOHOL - Disclosed are concentrate esmolol injection essentially free from other related esters of esmolol and diluted esmolol compositions. The concentrate esmolol formulation includes from about 25-1000 mg/ml of esmolol and about 1-25% w/v of benzyl alcohol and the combination thereof. The compositions can also be used as multi-dose compositions. The present invention also discloses diluted, ready-to-use compositions of esmolol prepared by dilution of the present invention concentrates. Also disclosed are methods of making and using the ready-to-use compositions of the present invention.2008-11-27
20080293811External preparation for the the skin - A skin treatment composition that characteristically contains alkylene polyglycol dineopentanoate having a specific structure.2008-11-27
20080293812Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates - Pamoic acid or its derivatives of formula (I) are used to treat diseases characterized by deposits of amyloid aggregates.2008-11-27
20080293813Compositions and Methods - Gaseous nitric oxide (NO) can be delivered to a mammal for prophylactic or therapeutic purposes using a composition capable of delivering NO, comprising a compound capable of forming a reversible bond or association with NO. Methods for the manufacture and use of said composition are disclosed.2008-11-27
20080293814CONCENTRATE ESMOLOL - A concentrate esmolol formulation is provided that is safer than current concentrate (e.g., 250 mg/ml) esmolol compositions. The concentrate esmolol formulation can include from about 40-60 mg/ml of esmolol hydrochloride. The concentrate esmolol composition allows a practitioner the flexibility of choosing a bolus volume for direct injection to a patient or, optionally, to use the composition to make a customized, diluted composition of esmolol. Methods of the present invention provide for the reduction of potential adverse health consequences resulting in the improper dosing of prior art concentrate compositions of esmolol. Also, a medical product is provided that includes a concentrate esmolol housed in a container, and a package housing the container and instructions.2008-11-27
20080293815HCA FOR IMPROVED HDL SERUM LIPIDS PROFILE - Described herein are compositions and methods for increasing serum high-density cholesterol lipoprotein (HDL) levels in an individual in need thereof comprising orally administering an effective amount of HCA.2008-11-27
20080293816Use of 2,5-Dihydroxybenzenesulphonic Acid in the Production of Medicaments for the Treatment of Angiodependent Diseases Such as Cancer and Psoriasis - The invention relates to the use of 2,5-dihydroxybenzenesulfonic acid in the production of medicaments for the treatment of angiodependent diseases. More specifically, the invention relates to the use of the aforesaid compound and, in particular, the calcium and potassium salts thereof, for the treatment of two angiodependent diseases, which present a reduction in the apoptosis, namely cancer and psoriasis. The invention also discloses the antiproliferative, antimigratory, antiangiogenic and proapoptotic capacity of said family of compounds in non-quiescent cells. In addition, the invention details the potentiating effect of said compounds on known cytostatic medicines in the treatment of tumours and, specifically, on gliomas. The invention further relates to the therapeutic efficacy of said compounds, based on the combined antiproliferative, antiangiogenic and proapoptotic capacities thereof, in the treatment of chronic psoriatic plaques.2008-11-27
20080293817ADMINISTRATION OF 6-[3-(1-ADAMANTYL)-4-METHOXYPHENYL]-2-NAPHTHOIC ACID FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS - Dermatological disorders having an inflammatory or proliferative component are treated with pharmaceutical compositions containing on the order of 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously topically applicable gels, creams or lotions.2008-11-27
20080293818Regulator of Physiological Function of Ghrelin and Use Thereof - A regulator for regulating physiological functions, such as activity of increasing an intracellular calcium ion concentration, activity of promoting growth hormone secretion, activity of promoting eating, regulatory activity relating to fat accumulation, activity of ameliorating heart function and activity of stimulating gastric acid secretion, of ghrelin, which regulator comprises a fatty acid of carbon number 2-35 or its derivative, and use thereof.2008-11-27
20080293819DI-FLUORO CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS - The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S, and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.2008-11-27
20080293820METHODS FOR IMPROVING PHYSICAL FUNCTION IN FIBROMYALGIA - Methods for improving physical function in fibromyalgia syndrome by administering an NSRI such as milnacipran as disclosed.2008-11-27
20080293821Cooling compositions - Disclosed are improved cooling compositions comprised of N-(2-hydroxyethyl)-2,3-dimethyl-2-isopropylbutyramide and at least one other cooling agent. The cooling compositions may be used alone or in products such as a chewing gum or a confection.2008-11-27
20080293822Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use - The invention provides novel arylbicyclo[3.1.0]hexylamines, and related processes and intermediates for preparing these compounds, as well as compositions and methods employing these compounds for the treatment and/or prevention of central nervous system (CNS) disorders, including but not limited to depression and anxiety.2008-11-27
20080293823Methods and Compositions For Treating Sleep-Related Breathing Disorders - Provided herein are methods of treating a sleep-related breathing disorder, such as obstructive sleep apnea, comprising the administration of O-desmethylvenlafaxine or duloxetine.2008-11-27
20080293824Pesticidal substituted piperidines - The invention relates to the use of phenylether derivatives of formula (I), to compositions thereof for the control of pests, including arthropods and helminths.2008-11-27
20080293825HYDROALCOHOLIC ANTIMICROBIAL COMPOSITION WITH SKIN HEALTH BENEFITS - The invention pertains to an alcohol based antimicrobial skincare composition. The invention also pertains to an alcohol based antimicrobial skincare composition with skin health benefits including moisturization and skin barrier maintenance effects. The invention further pertains to an alcohol based antimicrobial skincare composition that is a stable emulsion that has a certain viscosity to it that provides containment, for example on a user's hands. Finally, the invention pertains to an alcohol based antimicrobial skincare composition that may be used in the healthcare industry, for example as a surgical scrub, healthcare personnel handwash, or patient pre-operative site preparation.2008-11-27
20080293826COSMETIC COMPOSITIONS WITH ETHOXYLATED URETHANE - A cosmetic composition is provided which includes petrolatum, water, and ethoxylated urethane. This composition retains stable viscosity without being sticky or tacky and can easily be rubbed into skin.2008-11-27
20080293827Temperature and Ph Sensitive Block Copolymer and Polymeric Hydrogels Using the Same - Disclosed is a block copolymer formed by coupling the following components with each other: (a) a copolymer (A) of a polyethylene glycol (PEG) type compound with a biodegradable polymer; and (b) at least one oligomer (B) selected from the group consisting of poly(β-amino ester) and poly(amido amine). A method for preparing the same block copolymer, and a polymeric hydrogel type drug composition comprising the temperature and pH-sensitive block copolymer and a physiologically active substance that can be encapsulated with the block copolymer are also disclosed. The multiblock copolymer is obtained by copolymerization of a pH-sensitive poly(β-amino ester) and/or poly(amido amine) type oligomer, a hydrophilic and temperature-sensitive polyethylene glycol type compound and a hydrophobic and biodegradable polymer. Therefore, the block copolymer can form a polymeric hydrogel structure due to its amphiphilicity resulting from the combination of a hydrophilic group and a hydrophobic group in the copolymer and ionization characteristics depending on pH variations, and thus can be used as a drug carrier for target-directed drug delivery depending on pH variations in the body.2008-11-27
20080293828Use of Copolymers as Solubilizers For Slightly Water-Soluble Compounds - The use of copolymers obtained by free-radical polymerization of a mixture of 2008-11-27
20080293829Novel Compounds - This invention relates to newly identified ester-linked gemini surfactant compounds, to the use of such compounds and to their production. The invention also relates to the use of the ester-linked gemini surfactant compounds to facilitate the transfer of polynucleotides into cells.2008-11-27
20080293830Method For Activating Efferent Sympathetic Nerves Innervating Adipose Tissues To Improve Obesity And Symptoms Associated Therewith - A method for activating an efferent sympathetic nerve innervating an adipose tissue and improving obesity-associated symptoms is provided, comprising stimulating an afferent vagal nerve from the liver without directly enhancing peroxisome proliferator-activated receptor (PPAR)-γ2 function in the liver.2008-11-27
20080293831Method for producing zirconia sol - A production method of a zirconia sol includes; (A) mixing a dicarboxylic acid compound with a zirconium compound in an aqueous medium, in which a molar ratio of the dicarboxylic acid compound is more than 1 and less than or equal to 10 per mol of zirconium atom in the zirconium compound, and (B) adding 0.7-2.5 mol of a water-soluble organic base per mol of the dicarboxylic acid compound contained in a mixture obtained by the process (A) to the mixture and then treating hydrothermally the resultant mixture.2008-11-27
20080293832SOLID SAMPLE, SOLID SAMPLE FABRICATING METHOD, AND SOLID SAMPLE FABRICATING APPARATUS - A solid sample fabricating method includes preparing a specimen containing a first substance, which is in a liquid phase at normal temperature and normal pressure, and a second substance different from the first substance, which is in a solid or a liquid phase at the normal temperature and the normal pressure, the second substance being dispersed in the first substance, and attaching the specimen as a droplet to a surface of a cooled stage, whereby an entire region to be observed is converted into an amorphous state.2008-11-27
20080293833Carbon nanocapsule-layered silicate hybrid and preparation method thereof - A carbon nanocapsule-layered silicate hybrid is provided. Layered silicates (platelet-shaped) as a dispersant are mixed with carbon nanocapsules (sphere-shaped) by a physical process. The physically mixed hybrid exhibits a homogeneous dispersion phase due to the geometric shape inhomogeneity factor. Aggregation of carbon nanocapsules is thus avoided. The hybrid can be dispersed in a polar or non-polar solvent with a solid content of about 0.01-30 wt %.2008-11-27
20080293834Production of Liquid and, Optionally, Gaseous Hydrocarbons from Gaseous Reactants Into an Expanded Slurry Bed - A process for producing liquid and, optionally, gaseous products from gaseous reactants includes feeding at a low level a gaseous reactants feed comprising at least CO and H2008-11-27
20080293835PROCESS FOR DIRECTLY PRODUCING MIXED LINEAR ALPHA-ALCOHOLS HAVING 1 TO 18 CARBON ATOMS FROM SYNTHESIS GAS - The invention provide a process for producing directly mixed linear alpha-alcohols having 1 to 18 carbon atoms from synthesis gas comprising hydrogen and carbon monoxide, comprising the step of reacting hydrogen and carbon monoxide over a catalyst to produce mixed linear alpha-alcohols having 1 to 18 carbon atoms and hydrocarbons having 1 to 25 carbon atoms through Fischer-Tropsch process in one step in a reactor, wherein: the mole ratio of hydrogen to carbon monoxide is within the range of 1 to 3; the catalyst is an activated carbon supported cobalt based catalyst; the reactor is a fixed bed reactor, a slurry reactor or a fluid reactor; the reaction is carried out under specific conditions.2008-11-27
20080293836Method for the Recovery of Ruthenium From Used Ruthenium Oxide-Containing Catalysts - The invention relates to a process for recovering ruthenium from a used ruthenium-comprising catalyst which comprises ruthenium as ruthenium oxide on a support material which is sparingly soluble in mineral acid, which comprises the steps: 2008-11-27
20080293837Fluoropolymer Modified Acrylic Capstock - The invention relates to the use of an impact-modified acrylic blend with a low level of fluoropolymer to achieve impact resistance and solvent resistance in a capstock formulation. Preferably the acrylic blend contains a methyl methacrylate-based acrylic polymer and polyvinylidene fluoride.2008-11-27
20080293838Thermo-expansive microspheres, their production process and their application - The present invention provides a process for producing thermo-expansive microspheres comprising a thermoplastic resinous shell and a blowing agent being encapsulated in the shell, the blowing agent which is a fluorine-containing C2008-11-27
20080293839STABILIZED EXTRUDED ALKENYL AROMATIC POLYMER FOAMS AND PROCESSES FOR EXTRUDING STABILIZED ALKENYL AROMATIC POLYMER FOAMS - Prepare an extruded thermoplastic polymer foam having a thermoplastic polymer composition having defined therein multiple cells, the thermoplastic polymer foam containing at least one thermoplastic polymer, a brominated flame retardant, an epoxy containing organic compound and 180 weight parts or less of water extractable cations using a brominated flame retardant, an innocuous stabilizer and a blowing agent containing water.2008-11-27
20080293840POLYPHENYLENE-POLY(ARYL ETHER SULFONE) BLENDS, ARTICLES AND METHOD - Compositions comprising blends of polyphenylene and poly(aryl ether sulfone) and methods for making such blends are disclosed. Miscible blends of polyphenylene and poly(aryl ether sulfone) are also disclosed. The blends are useful in numerous applications such as in the preparation of articles and of foams having reduced density.2008-11-27
20080293841Polyester Polyol-Containing Polyurethane Systems Having Improved Hydrolytic Stability - An isocyanate reactive composition for making a polyurethane foam includes a tertiary amine urethane catalyst comprising a di(C1-C4)alkyl fatty alkyl amine and a polyester polyol. The use of one or more of fatty alkyl tertiary amine serves to reduce hydrolysis of the polyester polyol in the isocyanate reactive composition.2008-11-27
20080293842Self Assembled Nanotubes and Methods for Preparation Thereof - The invention concerns the synthesis of nanotubes and nanocarpets by the spontaneous self-assembly of single chain achiral diacetylenes The monomer units may be cross-linked by UV irradiation to form stable supramolecular assemblies. The nanotubes of the invention, which are remarkably homogeneous in length and diameter, exhibit chromogenic and antibacterial properties.2008-11-27
20080293843Comminutable Polyesters - A process is disclosed for producing a polyester in powder form, which process comprises: (a) rendering a polyester comminutable by (i) chemical pre-treatment of the polyester, or (ii) irradiating the polyester; and (b) comminuting the polyester produced in step (a) to form a powder.2008-11-27
20080293844Gels - The present invention relates to silicon-containing biostable gels and processes for their preparation. The gels possess properties which make them useful in the manufacture and repair of biomaterials and medical devices, articles or implants, in particular the manufacture of soft tissue implants such as breast implants and the repair of orthopaedic joints such as spinal discs.2008-11-27
20080293845Biodegradable Implant Polymers and Composites - Biodegradable oligomeric polyesters based upon hydroxy acids, such as glycolic acid (GA), lactic acid (LLA), and copolymers thereof are described. Composites that include biodegradable polyesters and bioabsorbable fillers are also described. The described polymers and composites are injectable and in situ curable.2008-11-27
20080293846Dental Compositions with Surface-Treated Filler for Shelf Stability - The invention features dental compositions containing a basic filler that has been surface-treated with a strong acid to increase the shelf life of the composition.2008-11-27
20080293847Disinfecting polymer and articles made therefrom - A disinfecting polymer composition is created for emitting chlorine dioxide for use in precluding microbial growth. Products containing the polymer are used for forming articles in the form of film, sheets, beads, or items extruded or molded from the polymer for protecting against contamination of foods, leather goods in transit, or other products otherwise subject to contamination.2008-11-27
20080293848SELF-POLISHING ANTI-FOULING COMPOSITIONS - A self-polishing anti-fouling marine coating composition that is free of heavy metal biocides. The coating composition comprises a polymer binder comprising a film forming polymer having a hydrolysable functional group on the polymer backbone; and a blend of at least two biocidally active materials, the blend comprising a 2-trihalogenomethyl-3-halogeno-4-cyanopyrrole compound and a second biocidally active material.2008-11-27
20080293849Nanocomposite Material Comprising Rubber and Modified Layered Double Hydroxide, Process for Its Preparation and Use Thereof - The present invention pertains to a nanocomposite material comprising rubber and a modified layered double hydroxide comprising: a charge-balancing organic ion having a first functional group and a second functional group, wherein at least part of the organic anions is chemically linked to the rubber through the second functional group; and/or a silane coupling agent having at least one alkoxysilane group and at least one reactive group, at least one alkoxysilane group being chemically linked to the layered double hydroxide, at least one reactive group being chemically linked to the rubber. The invention further pertains to a process for preparing the nanocomposite material or a precursor thereof.2008-11-27
20080293850Use of Comb Polymers as a Grinding Agent for Preparations Containing Cement - The present invention relates to the use of comb polymers which have a carbon backbone which bears polyether groups of the formula A2008-11-27
20080293851Use of Solid Pigment Preparations for Dyeing Composite Cellulose/Polymer Materials - Solid pigment preparations comprising, as essential constituents, 2008-11-27
20080293852Peroxide Vulcanizable Butyl Compositions Useful For Rubber Articles - The present invention is directed to a peroxide curable rubber compound containing a butyl rubber polymer, an olefin polymer of ethylene, at least one α-olefin and optionally at least one diene, and a high vinyl polybutadiene polymer. The present invention is also directed to a peroxide curable rubber compound containing a butyl polymer, an EP(D)M rubber polymer, and a 1,2-polybutadiene polymer.2008-11-27
20080293853METHOD FOR PRODUCING CARBON NANOTUBE/POLYMER MIXTURES BY GAS-PHASE POLYMERIZATION - The present invention relates to a novel method for producing polymer/carbon nanotube mixtures by gas-phase polymerization, optionally subsequent dispersion in a carbon nanotube/polymer composite, and in particular homogeneous carbon nanotube/polymer mixtures and carbon nanotube/polymer composites by in situ gas-phase polymerization of olefins or diolefins on carbon nanotubes, wherein the catalysts and, optionally, co-catalysts are supported on the carbon nanotubes.2008-11-27
20080293854Plastisols Based on a Methylmethacrylate Copolymer - The invention relates to plastisol systems with improved properties.2008-11-27
20080293855Composition of Polythiophene-Based Conductive Polymers Having High Conductivity, Transparency, Waterproof Property and a Membrane Prepared Using the Same - The present invention relates to a polythiophene-based conductive polymer composition having high conductivity, transparency, waterproof property and durability, and a polymer membrane prepared by using the same. In particular, the present invention relates to a polythiophene-based conductive polymer composition comprising an aqueous solution of a polythiophene-based conductive polymer, an alcohol-based organic solvent, an amide-based organic solvent or an aprotic highly-dipolar solvent, a melamine resin and a binder selected among a polyester, a polyurethane resin and an alkoxy silane in a predetermined mixed ratio. The membrane prepared using the same has a high conductivity of less than 1 kΩ/m2 and a high transparency of higher than 95%, thus being applicable to of an anti-static film, a film for touch panel, a film for higher or lower electrode, a film for inorganic EL and a film for display electrode.2008-11-27
20080293856Stabilized polyolefin compositions - Disclosed are compositions comprising antioxidants and stabilizers, such as, acid scavengers or organic phosphorus stabilizers, and optionally further comprising co-stabilizers. The disclosed compositions are useful as stabilizers for polyolefins and other polymeric materials. The disclosed compositions and methods generally provide longer shelf lives and better oxidative resistance to materials than currently available antioxidants.2008-11-27
20080293857Polyester Compositions Containing Cyclobutanediol Having a Certain Combination of Inherent Viscosity and Moderate Glass Transition Temperature and Articles Made Therefrom - Described are dialysis filter housings comprising polyester compositions comprising polyesters which comprise (a) a dicarboxylic acid component having terephthalic acid residues; optionally, aromatic dicarboxylic acid residues or aliphatic dicarboxylic acid residues or ester residues thereof; 2,2,4,4-tetramethyl-1,3-cyclobutanediol residues; and 1,4-cyclohexanedimethanol residues.2008-11-27
20080293858METHOD FOR MAKING ALKOXY-MODIFIED SILSESQUIOXANES - A method is presented for making alkoxy-modified silsesquioxanes (AMS) or co-alkoxy-modified silsesquioxanes (co-AMS,) comprising the steps of (a) combining as a reaction mixture (i) water, (ii) an acid-stable solvent for the water, (iii) a solid strong cationic hydrolysis and condensation catalyst, and (iv) a trialkoxysilane compound, (b) allowing the reaction mixture to react for about 0.5 hours to about 200 hours to form the alkoxy-modified silsesquioxanes; and (c) recovering the alkoxy-modified silsesquioxanes from the reaction mixture. The use of solid strong cationic catalysts in this reaction system is advantageous because they remain as solids throughout the reaction, allowing simplified separation of the solid catalyst from the soluble AMS or co-AMS products, resulting in total or near total recovery of the AMS or co-AMS products, the products being free of, or substantially free of residual acid catalyst, as well as virtual total recovery of the catalyst for recycling. The improved AMS and co-AMS compounds, vulcanizable rubber compounds containing them, and a pneumatic tire having a component made from the vulcanized rubber compounds are also presented.2008-11-27
20080293859CURABLE FLUOROPOLYETHER COMPOSITION AND INTEGRAL MOLDED RESIN/RUBBER ARTICLES - Curable fluoropolyether compositions comprising (a) a polyfluorodialkenyl compound, (b) a fluorinated organohydrogenpolysiloxane, (c) a platinum catalyst, (d) hydrophobic silica powder, (e) a tackifier in the form of a specific silicon compound, and (f) an organosiloxane having a SiH group, an epoxy and/or trialkoxysilyl group, and a perfluoroalkyl or perfluoropolyether group cure to thermoplastic resins to form a durable tight bond at a low temperature within a short time and are readily releasable from metal molds.2008-11-27
20080293860Branched Olefin Compositions - Olefin compositions comprising C2008-11-27
20080293861Composition of high impact glass fiber reinforced engineering plastic and preparation method thereof - A composition of a high impact glass fiber reinforced engineering plastic and a preparation method thereof, including except for glass fiber, from 30% to 70% by weight of a polyamide6 (PA6), from 15% to 25% by weight of an acrylonitrile-butadiene-styrene copolymer (ABS), from 4% to 6% by weight of a compatilizer, from 0.3% to 0.5% by weight of an antioxidant, and from 0.3% to 0.6% by weight of a lubricant are firstly added into a high-speed mixer and then mixed for 2-5 min. The blend composition is fed into a twin screw extruder, and from 10% to 30% by weight of a glass fiber is added into the twin screw extruder at the second half stage, and ground together to be granulated and molded. During the preparation, the process temperature is from 180° C. to 245° C., the screw rotating speed is from 240 rpm to 560 rpm.2008-11-27
20080293862Aqueous ink for inkjet - An aqueous ink for an inkjet, comprising a pigment, a polymer compound that coats the pigment, a water-soluble organic solvent, and water, wherein the polymer compound has a β-diketone group and a cationic salt-forming group, and also includes a cross-linked structure based on a siloxane linkage.2008-11-27
20080293863FLUORINATED POLYMER AND FLUORINATED POLYMER COMPOSITION CONTAINING IT - To provide an amorphous fluorinated polymer which is soluble in a fluorinated solvent having a boiling point of at most 70° C., and a fluorinated polymer composition containing it.2008-11-27
20080293864NONLINEAR POLYMER COMPOSITES AND METHODS OF MAKING THE SAME - A nonlinear composition comprises a polymeric material and at least one ferroelectric, antiferroelectric, or paraelectric particle, wherein the composition has a permittivity greater than or equal to about 5. A method of making a nonlinear composition comprises combining a polymeric material, and at least one ferroelectric, antiferroelectric, or paraelectric particle. The composition has a permittivity greater than or equal to about 5.2008-11-27
20080293865ROOM TEMPERATURE-CURABLE ORGANOPOLYSILOXANE COMPOSITION - An RTV organopolysiloxane composition comprises (A) an organosiloxane polymer comprising R2008-11-27
20080293866COMPOSITE COUNTERWEIGHT AND METHOD OF MAKING SAME - A composite material comprises a particulate material generated as a waste by-product of an industrial process, and a binder for binding the particulate material into a uniform mass. The particulate material and binder are combined in preselected proportions and compressed to form a counterweight having a preselected density and a fixed configuration. A counterweight is manufactured by selecting a first proportion of a particulate material generated as a waste by-product of an industrial process, selecting a second proportion of a binder for binding the particulate material into a uniform mass, combining the first proportion of the particulate material with the second proportion of the binder into a uniform mass, forming the counterweight from the uniform mass, and incorporating the counterweight into a finished product.2008-11-27
20080293867Thermally Stable Aluminum Hydroxide Particles and Their Use as Fillers in Epoxy Laminate Resins - Aluminum hydroxide particles having improved thermal stability and their use as a flame retardant in resins suitable for use in epoxy laminates, and laminates containing the same.2008-11-27
20080293868NITRILE RUBBERS - An improved polymerization and work-up process makes it possible to produce specific nitrile rubbers which have a particular ion index and a particular magnesium content which is responsible for an excellent vulcanization rate and leads to vulcanizates having an advantageous property profile.2008-11-27
20080293869NITRILE RUBBERS - An improved polymerization and work-up process makes it possible to produce specific nitrile rubbers which have a particular ion index which is responsible for an excellent vulcanization rate and leads to vulcanizates having an advantageous property profile.2008-11-27
20080293870Curing Agents for Epoxy Resins - Curing agent for epoxy resins, consisting of A) 1%-99% by weight of an adduct obtainable by reacting a1) a poly-ethylene polyamine having up to six nitrogens in the molecule with a2) a monoglycidyl ether, the adduct of a1) and a2) preferably being isolated by removal of the excess polyethylene polyamine, and B) 99%-1% by weight of an adduct obtainable by reacting b1) a diamine or polyamine with b2) acrylonitrile and/or C) 99%-1% by weight of a polyaminoamide, and also curable compositions further comprising an epoxide compound, and the use of these curable compositions for producing mouldings and sheetlike structures, and also for applications in the adhesives and sealants sector and for epoxy-resin mortars.2008-11-27
20080293871HIGHLY DISPERSIBLE PRECIPITATED SILICA HAVING A HIGH SURFACE AREA - The present invention relates to a highly dispersible silica which has a high surface area, a process to manufacture the aforesaid silica and its use as a tire filler for utility vehicles, motor cycles and high speed vehicles.2008-11-27
20080293872ADHESIVES, SEALANTS AND COATINGS CONTAINING GLASS PARTICLES AS A FILLER - The invention relates to chemically or physically curable compositions suitable as adhesives or sealants or coating materials, such compositions containing at least one binding agent selected from the group comprising crosslinkable or polymerizable monomers, prepolymers, or polymers, as well as at least one filler. The filler proportion is 0.2 to 70 wt % based on the total weight of the compositions, and at least a portion of the filler is made up of glass particles having a particle size from 100 nm to 20 μm, which have been obtained by comminuting foamed neutral or alkaline glass.2008-11-27
20080293873Water resistant molding material and producing method for the same - The invention provides a water resistant molding material that can be stably manufactured while being excellent in water resistance after dried, and a producing method for the water resistant molding material. The water resistant molding material comprises a binder resin containing a polyvinyl alcohol resin, a viscosity control agent, water and a filler, wherein the concentration of acetate ions is adjusted in the range from 500 to 12,000 ppm by blending, for example, an acetate ion controlling agent (such as NH2008-11-27
20080293874Polymers for the Dispersion of Pigments and Fillers - The invention relates to a polymer of the formula (I)2008-11-27
20080293875Oxetane Compound and Curable Composition Containing the Same - An object of the present invention is to provide a curable composition which: is excellent in reactivity, in particular, cationic polymerizability with respect to light and heat; and has good heat resistance. The object is carried out by an oxetane compound producible by a reaction between a silane compound having an epoxy group and an alkoxysilyl group, and a compound having an oxetane ring and an active hydrogen group.2008-11-27
20080293876Use of a crosslinkable silicone-based inverse emulsion for producing "breathable waterproof" coatings - Silicone coating on various soft supports, for instance textiles, made of synthetic polymers (polyamide, polyester) provides an efficient method for producing water impermeable and water permeable coatings, on soft supports, said method enabling to improve permeability to water vapor of the silicones while preserving impermeability to water. The inventive method enabling this consists mainly in: coating one of the surfaces of the support with a film formed by an invert water-in-oil silicone emulsion comprising a continuous oily silicone phase phi s, crosslinkable into elastomer and including a polyorganosiloxane (POS) A crosslinkable by addition polymerization, by cationic process or free-radical process; optionally a crosslinking organosilicon compound B; and optionally at least a catalyst C; an aqueous phase phi a; a stabilizing agent; and in ensuring crosslinking of the silicone phase phi s and elimination of water. The invention also concerns water impermeable and water vapor permeable soft polyamide or polyester substrates obtained by using an invert water-in-oil silicone emulsion.2008-11-27
20080293877Fireproof Composition - The present invention concerns a fireproof composition consisting of reticulated polysiloxane and raw carbon nanotubes with a “bound rubber” value greater than or equal to 15 grams of carbon nanotube, said carbon nanotubes representing between 0.05 and 1% of the total weight of said composition.2008-11-27
20080293878Ionically and/or Organometallically Functionalized Silicone Polymers Crosslinkable to High-Strength Elastomers - High strength silicone elastomers with enhanced physical properties are prepared from silicone polymers having ionic or organometallic functional groups, crosslinked through coulombic interactions and/or covalent bonds.2008-11-27
Website © 2022 Advameg, Inc.